Correlation Between Instil Bio and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Akari Therapeutics PLC, you can compare the effects of market volatilities on Instil Bio and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Akari Therapeutics.
Diversification Opportunities for Instil Bio and Akari Therapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Instil and Akari is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Instil Bio i.e., Instil Bio and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Instil Bio and Akari Therapeutics
Considering the 90-day investment horizon Instil Bio is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Instil Bio is 1.26 times less risky than Akari Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 91.00 in Akari Therapeutics PLC on January 12, 2025 and sell it today you would earn a total of 16.00 from holding Akari Therapeutics PLC or generate 17.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Instil Bio vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Instil Bio |
| Akari Therapeutics PLC |
Instil Bio and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Instil Bio and Akari Therapeutics
The main advantage of trading using opposite Instil Bio and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Instil Bio vs. Assembly Biosciences | Instil Bio vs. Nuvation Bio | Instil Bio vs. NextCure | Instil Bio vs. CytomX Therapeutics |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |